Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis.
暂无分享,去创建一个
Leo Koenderman | S. E. Jacobsen | P. Coffer | L. Koenderman | M. Buitenhuis | L. P. Verhagen | H. W. V. van Deutekom | A. Castor | S. Verploegen | Sandra Verploegen | Miranda Buitenhuis | Liesbeth P Verhagen | Hanneke W M van Deutekom | Anders Castor | Sten-Eirik W Jacobsen | Paul J Coffer | Hanneke W. M. van Deutekom | H. W. van Deutekom | S. Jacobsen
[1] J. Blenis,et al. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] O. MacDougald,et al. Glycogen Synthase Kinase 3 Is an Insulin-Regulated C/EBPα Kinase , 1999, Molecular and Cellular Biology.
[3] Hong Liu,et al. Involvement of Protein Kinase Cε in the Negative Regulation of Akt Activation Stimulated by Granulocyte Colony-Stimulating Factor1 , 2006, The Journal of Immunology.
[4] D. Tenen,et al. Phosphorylation of C/EBPα Inhibits Granulopoiesis , 2004, Molecular and Cellular Biology.
[5] C. Potter,et al. Drosophila Tsc1 Functions with Tsc2 to Antagonize Insulin Signaling in Regulating Cell Growth, Cell Proliferation, and Organ Size , 2001, Cell.
[6] P. Piccaluga,et al. Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients , 2006, Leukemia.
[7] T. Graf,et al. Lineage commitment of transformed haematopoietic progenitors is determined by the level of PKC activity. , 1996, The EMBO journal.
[8] D. Guertin,et al. Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton , 2004, Current Biology.
[9] C. Sugimoto,et al. PI3K/Akt and apoptosis: size matters , 2003, Oncogene.
[10] B. Burgering,et al. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction , 1995, Nature.
[11] J. Lammers,et al. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells. , 2003, Blood.
[12] W. V. van Blitterswijk,et al. Protein Kinase Cζ Is a Negative Regulator of Protein Kinase B Activity* , 1999, The Journal of Biological Chemistry.
[13] D. Tenen,et al. Phosphorylation of C/EBPalpha inhibits granulopoiesis. , 2004, Molecular and cellular biology.
[14] I. Weissman,et al. Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.
[15] Hong Yang,et al. ANG II stimulation of neuritogenesis involves protein kinase B in brain neurons. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[16] M. Birnbaum,et al. Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.
[17] D. Tenen,et al. CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors , 1998, Molecular and Cellular Biology.
[18] I. Weissman,et al. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.
[19] D. Tenen,et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] N. Hay,et al. The Akt-mTOR tango and its relevance to cancer. , 2005, Cancer cell.
[21] R. Loewith,et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive , 2004, Nature Cell Biology.
[22] Xi C. He,et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention , 2006, Nature.
[23] E. Solary,et al. Essential role for the p110delta isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia. , 2005, Blood.
[24] I. Weissman,et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.
[25] K. Kaibuchi,et al. Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells , 2002, Molecular and Cellular Biology.
[26] E. Solary,et al. Essential role for the p110δ isoform in phosphoinositide 3-kinase activation and cell proliferation in acute myeloid leukemia , 2005 .
[27] G. Thomas,et al. Disruption of the Mouse mTOR Gene Leads to Early Postimplantation Lethality and Prohibits Embryonic Stem Cell Development , 2004, Molecular and Cellular Biology.
[28] M. Raffeld,et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma , 2006, The Journal of experimental medicine.
[29] W L Stanford,et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.
[30] R. Hresko,et al. mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* , 2005, Journal of Biological Chemistry.
[31] K. Okkenhaug,et al. Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.
[32] Andrius Kazlauskas,et al. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase , 1995, Cell.
[33] Hong Wu,et al. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[34] J. Stock,et al. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta. , 2003, The Journal of clinical investigation.
[35] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[36] J. Lammers,et al. Signal transducer and activator of transcription 5 a ( STAT 5 a ) is required for eosinophil differentiation of human cord blood – derived CD 34 cells , 2002 .
[37] J. Woodgett,et al. Negative regulation of phosphatidylinositol 3-kinase and Akt signalling pathway by PKC. , 2003, Cellular signalling.
[38] Jennifer Skeen,et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. , 2003, Genes & development.
[39] J. Myklebust,et al. Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34(+) hematopoietic progenitor cells. , 2002, Experimental hematology.
[40] R. Moon,et al. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation , 2006, Nature Medicine.
[41] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[42] O. MacDougald,et al. Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase. , 1999, Molecular and cellular biology.
[43] E. Wilder,et al. Cell-autonomous regulation of cell and organ growth in Drosophila by Akt/PKB , 1999, Nature Cell Biology.
[44] E. Furth,et al. Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. , 2001, Nature medicine.
[45] J. Lammers,et al. Differential regulation of granulopoiesis by the basic helix-loop-helix transcriptional inhibitors Id1 and Id2. , 2005, Blood.
[46] I. Roninson,et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. , 2001, Genes & development.
[47] F. Alt,et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. , 1999, Science.